The Study
Features of correction of vitamin D deficiency in patients with diabetic kidney disease: the role of vitamin D-binding protein
This study looked at a group of people with diabetes and kidney problems and noticed that those with more of a certain protein in their blood didn't respond as well to vitamin D pills. But it didn't test if the protein was the reason — maybe their kidneys were just sicker, which caused both the high protein and the poor response.
Analysis score
Maximum 72 for a cohort study.
Where the score came from
People with type 2 diabetes and early kidney disease often have very low vitamin D. Giving them vitamin D pills helps most, but if they have too much of a special protein (VDBP) in their blood, the vitamin doesn't work as well.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 561 / 100
Quality score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — even though vitamin D pills raised levels for most, high VDBP blocked the benefit for nearly one-third of patients, meaning their bodies couldn't use the vitamin properly.
- 2After 3 months of 4000 IU vitamin D daily: vitamin D levels rose from 12.1 to 34.5 ng/mL; PTH dropped from 74.9 to 64.5 pg/mL; patients who didn't reach target levels had VDBP of 274.7 ng/mL, while those who did had only 127.2 ng/mL.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
KIDNEYS
Year
2025
Authors
V. Yerokhovych, O. Karpenko, Ye.I. Ilkiv, N. Kobyliak, I. Paliienko, I. Krasiuk, Iuliia Komisarenko
Related Content
Claims (6)
Taking dietary supplements restores missing micronutrients from inadequate food intake and maintains normal bodily functions.
People with type 2 diabetes and early kidney disease consistently show low vitamin D levels in their blood, and the worse their kidney function, the lower their vitamin D levels tend to be.
In people with type 2 diabetes and early kidney disease, those with higher levels of vitamin D-binding protein in their blood at the start of treatment are less likely to reach healthy vitamin D levels after three months of taking vitamin D supplements.
In people with type 2 diabetes, higher levels of vitamin D-binding protein in the blood are consistently observed as kidney function worsens, with measurable increases from 93.6 ng/mL to 132.8 ng/mL as eGFR declines from ≥90 to 30–60 mL/min/1.73m².
In people with type 2 diabetes and kidney disease, taking 4000 IU of vitamin D daily for three months raises blood levels of vitamin D from 12.1 ng/mL to 34.5 ng/mL.
In people with type 2 diabetes and chronic kidney disease, taking vitamin D supplements for three months lowers parathyroid hormone levels from 74.9 pg/mL to 64.5 pg/mL, which reflects improved mineral metabolism and reduced secondary hyperparathyroidism.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.